EDUCATING LEADERS IN PHARMACY AND PHARMACEUTICAL SCIENCES SINCE 1886
Jacobs receives competitive NIH Clinical Loan Repayment Program Award
Published September 6, 2017 This content is archived.
David Jacobs, clinical assistant professor, pharmacy practice, is the recipient of a 2017 National Institutes of Health (NIH) Clinical Loan Repayment Program (LRP) Award from the National Heart, Lung and Blood Institute.
This competitive funding is given to counteract the financial pressure of student loans for clinical investigators by repaying a percentage of the researcher’s qualified educational debt in return for a commitment to engage in NIH-mission oriented research. Typically, these funds are awarded to MDs or PhDs—Jacobs’ ability to secure this funding is highly noteworthy. In 2016, out of the 171 non-MD/PhD proposals submitted, 81 proposals were awarded nationally.
Jacobs’ research proposal, entitled “Clinical Epidemiology in Chronic Obstructive Pulmonary Disease,” included three different projects focused on clinical epidemiology and health services research among COPD patients. This award allows Jacobs to build and sustain his research career in pharmacy and community health to promote health, prevent disease and advance public health policies.
For over 130 years, the University at Buffalo School of Pharmacy and Pharmaceutical Sciences has continually been a leader in the education of pharmacists and pharmaceutical scientists, renowned for innovation in clinical practice and research. The school is accredited by the American Council of Pharmaceutical Education (ACPE) and ranked as one of the top 25 schools of pharmacy and pharmaceutical sciences in the United States.